Sciele Pharma Inc. v. Lupin Ltd.

Opinion

N0'[‘E: ThiS order is n0nprecedent,ia1. Um'ted States Court of AppeaIs fo1:the FederaI Circuit SCIELE PHARMA INC. (NOW KNOWN AS SHIONOGI PHARMA INC.), ANDRX CORPORA'l`ION, ANDRX PHARMACEUTICALS INC. (DOING BUSINESS AS WATSON LABORATORIES INC. - FL()RIDA), ANDRX PHARMACEUTICALS L.L.C., ANDRX LABORATORIES (NJ) INC., ANDRX EU LTD., AND ANDRX LABS L.L.C., Plaintiffs-Appellees, V. LUPIN LTD. AND LUPIN PHARMACEUTICALS INC., Defer1do:n,tS-Appellants, AND 1V[YLAN INC. AND MYLAN PHARMACEUTICALS INC., Defendan,ts. 2012-1113 AppeaI from the Unit.ed Stat0ss DiStrict C0urt for the DiSt1'ict of De1z1War@ in consolidated case n0. 09-CV-0037, Judge R0bert B. Kug1er.

sc1ELE PHARMA v. LUP1N LTD ON MOTION MOORE, C'ircuit Ju,dge. 0 R D E R pedite the issuance of the mandate, 4 I'r ls ORDERED THAT: FOR THE COURT FEB 2 2 2913 131 Jan H@rb:a1y Date J an H01'ba1y C1erk cc: David B. Bassett, Esq. § Doug1ass C. Hochstet1er, Esq. 1 Mary B. Matterer, Esq. Issued As A Mandate: 2 2 2012 s24 .'. , , ,1,_,,____...,___ »~ '.»,__ irs 7 Bef0re LOURIE, PROST, and MOORE, Circuit Ju,dges. 2 Upon consideration of the parties joint motion to ex- The motion is granted The mandate shall issue t0day. s= 9 Zc-.~ “‘E 33 cl-i-|1 so- >El-1 'U EALS FDB CfRGUlT FEB 2 2 2012 JAN HORBALY CLERK